This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
3.VM Montori , GH. Guyatt Progress in evidence-based medicine. JAMA. 2008;300:1814–6.
4.AR Feinstein , RI. Horwitz Problems in the “evidence” of “evidence-based medicine”. Am J Med. 1997;103:529–35.
5.KF Schulz , DG Altman , D Moher , CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152:726–32.
6.A Hirst , DG. Altman Are peer reviewers encouraged to use reporting guidelines? survey of 116 health research journals. PLoS One. 2012;7:e35621.
8.O Berwanger , RA Ribeiro , A Finkelsztejn , et al.The quality of reporting of trial abstracts is suboptimal: survey of major general medical journals. J Clin Epidemiol. 2009;62:387–92.
9.AA Shukralla , C Tudur-Smith , GA Powell , PR Williamson , AG. Marson Reporting of adverse events in randomised controlled trials of antiepileptic drugs using the CONSORT criteri for reporting harms. Epilepsy Res. 2011;97:20–9.
10.R Assadi , N Zarghi , Shamloo A Sapehri , Y. Nikooiyan Evidence-based abstracts: what research summaries should contain to support evidence-based medicine. Int J Evid Based Healthc. 2012;10:154–8.
12.EN Kiehna , RM Starke , N Pouratian , AS. Dumont Standards for reporting randomized controlled trials in neurosurgery. J Neurosurg. 2011;114:280–5.
13.AW Rutjes , JB Reitsma , M Di Nisio , N Smidt , JC van Rijn , Bossuyt PM. Evidence of bias and variation in diagnostic accuracy studies. CMAJ. 2006;174:469–76.
15.PM. Bossuyt STARD statement: still room for improvement in the reporting of diagnostic accuracy studies. Radiology. 2008;248:713–4.
16.HJ Schunemann , AD Oxman , J Brozek , et al.Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008;336:1106–10.
17.AS Hess , M Shardell , JK Johnson , et al.Methods and recommendations for evaluating and reporting a new diagnostic test. Eur J Clin Microbiol Infect Dis. 2012;31:2111–6.
19.D Atkins , M Eccles , S Flottorp , et al.Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res. 2004;4:38.
20.D Atkins , PA Briss , M Eccles , et al.Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system. BMC Health Serv Res. 2005;5:25.
21.GH Guyatt , AD Oxman , GE Vist , et al.GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–6.
22.GH Guyatt , AD Oxman , R Kunz , et al.What is “quality of evidence” and why is it important to clinicians? BMJ. 2008;336:995–8.
23.GH Guyatt , AD Oxman , R Kunz , et al.Going from evidence to recommendations. BMJ. 2008;336:1049–51.
24.GH Guyatt , AD Oxman , R Kunz , et al.Incorporating considerations of resources use into grading recommendations. BMJ. 2008;336:1170–3.
25.G Guyatt , AD Oxman , EA Akl , et al.GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383–94.
26.J Thornton , P Alderson , T Tan , et al.Introducing GRADE across the NICE clinical guideline program. J Clin Epidemiol. 2013 Feb;66(2):124–31.
27.TA Nakagawa , S Ashwal , M Mathur , M Mysore , Committee For Determination Of Brain Death In Infants Children. Guidelines for the determination of brain death in infants and children: an update of the 1987 task force recommendations-executive summary. Ann Neurol. 2012;71:573–85.
29.MJ Goldenberg , K Borgerson , R. Bluhm The nature of evidence in evidence-based medicine: guest editors’ introduction. Perspect Biol Med. 2009;52:164–7.
30.R. Upshur Making the grade: assuring trustworthiness in evidence. Perspect Biol Med. 2009;52:264–75.
34.AR Jadad , MW. Enkin Randomized controlled trials. Oxford, UK: Blackwell Publishing BMJI Books, 2007.
35.JG Burneo , BM Demaerschalk , ME Jenkins , editors. Neurology: An evidence-based approach. New York: Springer2012.
37.G Gronseth , J. French Practice parameters and technology assessments: what they are, what they are not, and why you should care. Neurology. 2008;71:1639–43.
38.J French , G. Gronseth Lost in a jungle of evidence: we need a compass. Neurology. 2008;71:1634–8.
39.F. Brigo New anti-epileptic drugs: overcoming the limits of randomised controlled trials. Int J Evid Based Healthc. 2011;9:440–3.
40.RH Mattson , JA Cramer , Escuet AV Delgado , DB Smith , JF. Collins A design for the prospective evaluation of the efficacy and toxicity of antiepileptic drugs in adults. Neurology. 1983;33:14–25.
41.RH Mattson , JA Cramer , JF Collins , et al.Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med. 1985;313:145–51.
42.Anonymous. Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy. Epilepsia. 1998;39:952–9.
43.S Wiebe , WT Blume , JP Girvin , M Eliasziw , Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345:311–8.
45.DS Goodin , AT. Reder Evidence-based medicine: promise and pitfalls. Mult Scler. 2012;18:947–8.
46.GS Gronseth , E. Ashman The AAN response to evidence-based medicine: promise and pitfalls. Mult Scler. 2012;18:949–50.
48.DJ Cooper , JV Rosenfeld , L Murray , et al.Decompressive craniectomy in diffuse traumatic brain injury. N Engl J Med. 2011;364:1493–502.
50.S Honeybul , KM Ho , CR. Lind What Can Be Learned from the DECRA Study. World Neurosurg. 2013;79:159–61.
51.C Iaccarino , P Schiavi , F. Servadei Decompressive Craniectomies: Time to Discuss Not the DECR Study but the Comments to the DECRA Study. World Neurosurg. 2013;79:78–9.
52.PJ Hutchinson , I Timofeev , AG Kolias , et al.Decompressive craniectomy for traumatic brain injury: the jury is still out. Br J Neurosurg. 2011;25:441–2.
53.J. Lemcke Taming tyrannosaur: the decompressive craniectomy for traumatic brain injury has to become an evidence-based procedure. Eur J Neurol. 2011;18:543–4.
54.JH. Chi Craniectomy for traumatic brain injury: results from the DECRA trial. Neurosurgery. 2011;68:N19–20.
55.R. Torres DECRA…Where do we go from here? Surg Neurol Int. 2012;3:54.
56.RS Kitagawa , MR. Bullock Lessons from the DECRA Study. World Neurosurg. 2013;79:82–4.
57.DJ Cooper , JV Rosenfeld , R. Wolfe DECRA Investigators’ Response to “The Future of Decompressive Craniectomy for Diffuse Traumatic Brain Injury” by Honeybul et al. J Neurotrauma. 2012;29:2595–6.
58.JM. Drazen Believe the data. N Engl J Med. 2012;367:1152–3.
59.Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA. 1992;268:2420–5.
60.G Kahlon , IA Mansi , DE. Banks Educating medical students in evidence-based medicine: what we should expect as a starting point for our house officers. South Med J. 2012;105:184–8.
61.A. Booth Evidence-based practice: triumph of style over substance? Health Info Libr J. 2011;28:237–41.
62.M. Rawlins De testimonio: on the evidence for decisions about the use of therapeutic interventions. Lancet. 2008;372:2152–61.
63.MD. Rawlins De Testimonio: On the evidence for decisions about the use of therapeutic interventions. London, UK: Royal College of Physicians, 2008.
65.DL Sackett , WM Rosenberg , JA Gray , RB Haynes , WS. Richardson Evidence based medicine: what it is and what it isn’t. BMJ. 1996;312:71–2.
66.JL. Mills Dat torturing. N Engl J Med. 1993;329:1196–9.
67.T. Greenhalgh How to read a paper. Statistics for the non-statistician. II: “Significant” relations and their pitfalls. BMJ. 1997;315:422–5.
68.S Senn , S. Julious Measurement in clinical trials: a neglected issue for statisticians? Stat Med. 2009;28:3189–209.
70.J Matcham , S Julious , S Pyke , et al.Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials. Pharm Stat. 2011;10:70–3.
71.BA Mansi , J Clark , FS David , et al.Ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research: a joint journal and pharmaceutical industry perspective. Mayo Clin Proc. 2012;87:424–9.
72.JM. Drazen Transparency for Clinical Trials - The TEST Act. N Engl J Med. 2012;367(9):863–4.
73.D Strech , J. Littmann Lack of proportionality. Seven specifications of public interest that override post-approval commercial interests on limited access to clinical data. Trials. 2012;13:100.
74.AS Kesselheim , B Wang , DM Studdert , J. Avorn Conflict of interest reporting by authors involved in promotion of off-label drug use: an analysis of journal disclosures. PLoS Med. 2012;9:e1001280.
75.P Crosskerry , GR. Nimmo Better clinical decision making and reducing diagnostic error. J R Coll Physicians Edinb. 2011;41:155–62.
76.P Croskerry , AA Abbass , AW. Wu How doctors feel: affective issues in patients’ safety. Lancet. 2008;372:1205–6.
77.P. Croskerry Context is everything or how could I have been that stupid? Healthc Q. 2009;12 Spec No Patient:e171–6.
78.P. Croskerry A universal model of diagnostic reasoning. Acad Med. 2009;84:1022–8.
79.P. Crosskerry Perspectives on diagnostic failure and patient safety. Healthc Q. 2012;15 suppl:50–6.
80.AB. Hill Medical ethics and controlled trials. Br Med J. 1963;1:1043–9.